 <h1>Abelcet Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>amphotericin b lipid complex</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about amphotericin b lipid complex. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Abelcet.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to amphotericin b lipid complex: suspension</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, amphotericin b lipid complex (the active ingredient contained in Abelcet) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking amphotericin b lipid complex:</p><p>
<i>More common</i>
</p><ul>
<li>Chills and fever</li>
<li>headache</li>
<li>nausea and vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Difficulty in breathing</li>
<li>sore throat and fever</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness and weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Increased or decreased urination</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of amphotericin b lipid complex may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>loss of appetite</li>
<li>stomach pain</li>
</ul><p>
<!-- end suspension --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amphotericin b lipid complex: intravenous suspension</i></p><h3>General</h3><p>The most common clinical side effects in clinical trials were chills, increased creatinine, pyrexia, hypokalemia, nausea, and vomiting.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Chills (up to 18%), fever/pyrexia (up to 14%), multiple organ failure (11%)</p>
<p><b>Common</b> (1% to 10%): Sepsis, infection, pain, chest pain, increased alkaline phosphatase</p>
<p><b>Frequency not reported</b>: Malaise, weight loss, increased lactate dehydrogenase, shivering, generalized edema, asthenia, peripheral edema</p><h3>Renal</h3><p><b>Very common</b> (10% or more): Increased serum creatinine (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Renal failure, renal impairment, increased BUN/urea</p>
<p><b>Frequency not reported</b>: Decreased renal function, abnormal kidney function</p>
<p><b>Postmarketing reports</b>: Renal tubular acidosis (including hyposthenuria, electrolyte imbalance [e.g., increased potassium, decreased magnesium]), nephrogenic diabetes insipidus<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, electrolyte imbalance (including increased blood potassium, decreased blood magnesium)</p>
<p><b>Frequency not reported</b>: Anorexia, hypomagnesemia, hyperkalemia, hypocalcemia, hypercalcemia, acidosis, hyperamylasemia, hypoglycemia, hyperglycemia, hyperuricemia, hypophosphatemia, hypernatremia, hyponatremia, hyperchloremia</p>
<p><b>Postmarketing reports</b>: Hyperammonemia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting, diarrhea, gastrointestinal hemorrhage, abdominal pain, nausea and vomiting</p>
<p><b>Frequency not reported</b>: Melena, dyspepsia, epigastric pain, cramping, constipation</p>
<p><b>Postmarketing reports</b>: Peritonitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia, leukopenia, anemia</p>
<p><b>Frequency not reported</b>: Coagulation defects, blood dyscrasias (including eosinophilia), leukocytosis, decreased thromboplastin</p>
<p><b>Postmarketing reports</b>: Pancytopenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, tremor</p>
<p><b>Uncommon</b> (0.1% to 1%): Convulsions, neuropathy</p>
<p><b>Frequency not reported</b>: Peripheral neuropathy, deafness, hearing loss, tinnitus, transient vertigo, cerebral vascular accident, extrapyramidal syndrome, other neurologic symptoms, somnolence</p>
<p><b>Postmarketing reports</b>: Encephalopathy, stupor<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Anaphylactic response</p>
<p><b>Frequency not reported</b>: Anaphylaxis, allergic reactions (including bronchospasm, wheezing, asthma), anaphylactoid reactions, infusion hypersensitivity reactions (including abdominal pain, nausea, vomiting, myalgia, pruritus, maculopapular rash, fever, hypotension, shock, bronchospasm, respiratory failure)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, cardiac arrest, hypertension, tachycardia, cardiac arrhythmias</p>
<p><b>Uncommon</b> (0.1% to 1%): Shock</p>
<p><b>Frequency not reported</b>: Cardiac failure, myocardial infarction, thrombophlebitis, cardiomyopathy, arrhythmias, ventricular fibrillation, atrial fibrillation, phlebitis, supraventricular tachycardia, abnormal ECG, cyanosis</p>
<p><b>Postmarketing reports</b>: Asystole, bradycardia, hemorrhage, vasodilation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Respiratory failure, dyspnea, pneumonia, respiratory disorder, asthma</p>
<p><b>Frequency not reported</b>: Wheezing, pulmonary edema, hemoptysis, tachypnea, pulmonary embolus, pleural effusion, hypoxia, lung disorder, pneumonia, hyperventilation, increased cough, pharyngitis, apnea</p>
<p><b>Postmarketing reports</b>: Bronchospasm<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Pruritus</p>
<p><b>Frequency not reported</b>: Maculopapular rash, erythema multiforme, skin ulcer, exanthema</p>
<p><b>Postmarketing reports</b>: Exfoliative dermatitis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Injection site reaction</p>
<p><b>Frequency not reported</b>: Injection site inflammation, injection site hypersensitivity<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Myalgia</p>
<p><b>Frequency not reported</b>: Myasthenia, bone pain, joint pain, muscle pain<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Hyperbilirubinemia, abnormal liver function tests</p>
<p><b>Frequency not reported</b>: Acute liver failure, jaundice, hepatitis, increased AST, increased ALT, veno-occlusive liver disease, hepatomegaly, cholangitis, cholecystitis, bilirubinemia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Oliguria, anuria, impotence, dysuria, hematuria, urinary tract infection, pyuria, urinary tract disorder</p>
<p><b>Postmarketing reports</b>: Hyposthenuria, incontinence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Visual impairment, diplopia</p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Confusion, insomnia, anxiety</p>
<p><b>Postmarketing reports</b>: Agitation</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Rapp RP, Gubbins PO, Evans ME "Amphotericin B lipid complex." Ann Pharmacother 31 (1997): 1174-86</p><p id="ref_2">2. Oravcova E, Mistrik M, Sakalova A, Drgona L, Kollar T, Helpianska L, Ilavska I, Sorkovska D, Spanik S, Kukuckova E, Krcmery V "Amphotericin b lipid complex to treat invasive fungal infections in cancer patients: report of efficacy and safety in 20 patients." Chemotherapy 41 (1995): 473-6</p><p id="ref_3">3. Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fanhavard P, Eng RHK, Patterson TF, "Amphotericin b lipid complex compared with amphotericin b in the treatment of cryptococcal meningitis in patients with AIDS." Clin Infect Dis 22 (1996): 315-21</p><p id="ref_4">4. Sundar S, Murray HW "Cure of antimony-unresponsive indian visceral leishmaniasis with amphotericin b lipid complex." J Infect Dis 173 (1996): 762-5</p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_6">6. Lopez-Velez R,  Videla S,  Marquez M, et al. "Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients." J Antimicrob Chemother 53 (2004): 540-3</p><p id="ref_7">7. Kline S, Larsen TA, Fieber L, Fishbach R, Greenwood M, Harris R, Kline MW, Tennican PO, Janoff EN "Limited toxicity of prolonged therapy with high doses of amphotericin b lipid complex." Clin Infect Dis 21 (1995): 1154-8</p><p id="ref_8">8. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_9">9. "Product Information. Abelcet (amphotericin B)." Liposome Company Inc, The, Princeton, NJ. </p><p id="ref_10">10. Gales MA, Gales BJ "Acute renal failure with amphotericin B in lipid emulsion." Ann Pharmacother 30 (1996): 1036</p><p id="ref_11">11. Sorkin P, Nagar H, Weinbroum A, Setton A, Israitel E, Scarlatt A, Silbiger A, Rudick V, Kluger Y, Halpern P "Administration of amphotericin b in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients." Crit Care Med 24 (1996): 1311-5</p><p id="ref_12">12. Rowles DM, Fraser SL "Amphotericin B lipid complex (ABLC)-associated hypertension: Case report and review." Clin Infect Dis 29 (1999): 1564-5</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Abelcet (amphotericin b lipid complex)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: polyenes</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Abelcet &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Aspergillosis, Aspergilloma</li>
<li>Aspergillosis, Invasive</li>
<li>Blastomycosis</li>
<li>Candidemia</li>
<li data-more-config-id="list-data-resources-conditions">... +4 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amphotericin b lipid complex: intravenous suspension</i></p><h3>General</h3><p>The most common clinical side effects in clinical trials were chills, increased creatinine, pyrexia, hypokalemia, nausea, and vomiting.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Chills (up to 18%), fever/pyrexia (up to 14%), multiple organ failure (11%)</p><p><b>Common</b> (1% to 10%): Sepsis, infection, pain, chest pain, increased alkaline phosphatase</p><p><b>Frequency not reported</b>: Malaise, weight loss, increased lactate dehydrogenase, shivering, generalized edema, asthenia, peripheral edema</p><h3>Renal</h3><p><b>Very common</b> (10% or more): Increased serum creatinine (up to 13%)</p><p><b>Common</b> (1% to 10%): Renal failure, renal impairment, increased BUN/urea</p><p><b>Frequency not reported</b>: Decreased renal function, abnormal kidney function</p><p><b>Postmarketing reports</b>: Renal tubular acidosis (including hyposthenuria, electrolyte imbalance [e.g., increased potassium, decreased magnesium]), nephrogenic diabetes insipidus<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, electrolyte imbalance (including increased blood potassium, decreased blood magnesium)</p><p><b>Frequency not reported</b>: Anorexia, hypomagnesemia, hyperkalemia, hypocalcemia, hypercalcemia, acidosis, hyperamylasemia, hypoglycemia, hyperglycemia, hyperuricemia, hypophosphatemia, hypernatremia, hyponatremia, hyperchloremia</p><p><b>Postmarketing reports</b>: Hyperammonemia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting, diarrhea, gastrointestinal hemorrhage, abdominal pain, nausea and vomiting</p><p><b>Frequency not reported</b>: Melena, dyspepsia, epigastric pain, cramping, constipation</p><p><b>Postmarketing reports</b>: Peritonitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia, leukopenia, anemia</p><p><b>Frequency not reported</b>: Coagulation defects, blood dyscrasias (including eosinophilia), leukocytosis, decreased thromboplastin</p><p><b>Postmarketing reports</b>: Pancytopenia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, tremor</p><p><b>Uncommon</b> (0.1% to 1%): Convulsions, neuropathy</p><p><b>Frequency not reported</b>: Peripheral neuropathy, deafness, hearing loss, tinnitus, transient vertigo, cerebral vascular accident, extrapyramidal syndrome, other neurologic symptoms, somnolence</p><p><b>Postmarketing reports</b>: Encephalopathy, stupor<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Anaphylactic response</p><p><b>Frequency not reported</b>: Anaphylaxis, allergic reactions (including bronchospasm, wheezing, asthma), anaphylactoid reactions, infusion hypersensitivity reactions (including abdominal pain, nausea, vomiting, myalgia, pruritus, maculopapular rash, fever, hypotension, shock, bronchospasm, respiratory failure)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, cardiac arrest, hypertension, tachycardia, cardiac arrhythmias</p><p><b>Uncommon</b> (0.1% to 1%): Shock</p><p><b>Frequency not reported</b>: Cardiac failure, myocardial infarction, thrombophlebitis, cardiomyopathy, arrhythmias, ventricular fibrillation, atrial fibrillation, phlebitis, supraventricular tachycardia, abnormal ECG, cyanosis</p><p><b>Postmarketing reports</b>: Asystole, bradycardia, hemorrhage, vasodilation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Respiratory failure, dyspnea, pneumonia, respiratory disorder, asthma</p><p><b>Frequency not reported</b>: Wheezing, pulmonary edema, hemoptysis, tachypnea, pulmonary embolus, pleural effusion, hypoxia, lung disorder, pneumonia, hyperventilation, increased cough, pharyngitis, apnea</p><p><b>Postmarketing reports</b>: Bronchospasm<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Pruritus</p><p><b>Frequency not reported</b>: Maculopapular rash, erythema multiforme, skin ulcer, exanthema</p><p><b>Postmarketing reports</b>: Exfoliative dermatitis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Injection site reaction</p><p><b>Frequency not reported</b>: Injection site inflammation, injection site hypersensitivity<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Myalgia</p><p><b>Frequency not reported</b>: Myasthenia, bone pain, joint pain, muscle pain<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Hyperbilirubinemia, abnormal liver function tests</p><p><b>Frequency not reported</b>: Acute liver failure, jaundice, hepatitis, increased AST, increased ALT, veno-occlusive liver disease, hepatomegaly, cholangitis, cholecystitis, bilirubinemia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Oliguria, anuria, impotence, dysuria, hematuria, urinary tract infection, pyuria, urinary tract disorder</p><p><b>Postmarketing reports</b>: Hyposthenuria, incontinence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Visual impairment, diplopia</p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Confusion, insomnia, anxiety</p><p><b>Postmarketing reports</b>: Agitation</p><p id="ref_1">1. Rapp RP, Gubbins PO, Evans ME "Amphotericin B lipid complex." Ann Pharmacother 31 (1997): 1174-86</p><p id="ref_2">2. Oravcova E, Mistrik M, Sakalova A, Drgona L, Kollar T, Helpianska L, Ilavska I, Sorkovska D, Spanik S, Kukuckova E, Krcmery V "Amphotericin b lipid complex to treat invasive fungal infections in cancer patients: report of efficacy and safety in 20 patients." Chemotherapy 41 (1995): 473-6</p><p id="ref_3">3. Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fanhavard P, Eng RHK, Patterson TF, "Amphotericin b lipid complex compared with amphotericin b in the treatment of cryptococcal meningitis in patients with AIDS." Clin Infect Dis 22 (1996): 315-21</p><p id="ref_4">4. Sundar S, Murray HW "Cure of antimony-unresponsive indian visceral leishmaniasis with amphotericin b lipid complex." J Infect Dis 173 (1996): 762-5</p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_6">6. Lopez-Velez R,  Videla S,  Marquez M, et al. "Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients." J Antimicrob Chemother 53 (2004): 540-3</p><p id="ref_7">7. Kline S, Larsen TA, Fieber L, Fishbach R, Greenwood M, Harris R, Kline MW, Tennican PO, Janoff EN "Limited toxicity of prolonged therapy with high doses of amphotericin b lipid complex." Clin Infect Dis 21 (1995): 1154-8</p><p id="ref_8">8. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_9">9. "Product Information. Abelcet (amphotericin B)." Liposome Company Inc, The, Princeton, NJ. </p><p id="ref_10">10. Gales MA, Gales BJ "Acute renal failure with amphotericin B in lipid emulsion." Ann Pharmacother 30 (1996): 1036</p><p id="ref_11">11. Sorkin P, Nagar H, Weinbroum A, Setton A, Israitel E, Scarlatt A, Silbiger A, Rudick V, Kluger Y, Halpern P "Administration of amphotericin b in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients." Crit Care Med 24 (1996): 1311-5</p><p id="ref_12">12. Rowles DM, Fraser SL "Amphotericin B lipid complex (ABLC)-associated hypertension: Case report and review." Clin Infect Dis 29 (1999): 1564-5</p><h2>More about Abelcet (amphotericin b lipid complex)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: polyenes</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Abelcet &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Aspergillosis, Aspergilloma</li>
<li>Aspergillosis, Invasive</li>
<li>Blastomycosis</li>
<li>Candidemia</li>
<li data-more-config-id="list-data-resources-conditions">... +4 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>